Rothschild Asset Management Inc. boosted its position in CME Group Inc. (NASDAQ:CME) by 8.8% during the second quarter, Holdings Channel reports. The institutional investor owned 9,104 shares of the financial services provider’s stock after buying an additional 740 shares during the period. Rothschild Asset Management Inc.’s holdings in CME Group were worth $1,140,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of CME. Huntington National Bank raised its stake in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after buying an additional 38 shares in the last quarter. DnB Asset Management AS raised its stake in shares of CME Group by 23.6% in the first quarter. DnB Asset Management AS now owns 36,715 shares of the financial services provider’s stock worth $4,362,000 after buying an additional 7,000 shares in the last quarter. Reliance Trust Co. of Delaware raised its stake in shares of CME Group by 4.0% in the first quarter. Reliance Trust Co. of Delaware now owns 7,814 shares of the financial services provider’s stock worth $929,000 after buying an additional 300 shares in the last quarter. Viking Fund Management LLC raised its stake in shares of CME Group by 21.7% in the first quarter. Viking Fund Management LLC now owns 28,000 shares of the financial services provider’s stock worth $3,326,000 after buying an additional 5,000 shares in the last quarter. Finally, Fox Run Management L.L.C. purchased a new stake in shares of CME Group during the first quarter worth $535,000. Institutional investors and hedge funds own 83.29% of the company’s stock.
CME Group Inc. (NASDAQ CME) opened at 126.19 on Thursday. The firm’s 50-day moving average price is $123.45 and its 200 day moving average price is $120.89. CME Group Inc. has a one year low of $98.95 and a one year high of $127.96. The firm has a market capitalization of $42.72 billion, a P/E ratio of 25.76 and a beta of 0.73.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business had revenue of $925 million during the quarter, compared to analyst estimates of $931.05 million. During the same period last year, the business posted $1.14 earnings per share. CME Group’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities analysts anticipate that CME Group Inc. will post $4.81 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a $0.66 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.64 annualized dividend and a yield of 2.09%. CME Group’s dividend payout ratio (DPR) is presently 53.99%.
ILLEGAL ACTIVITY NOTICE: “Rothschild Asset Management Inc. Boosts Stake in CME Group Inc. (NASDAQ:CME)” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/2797620/rothschild-asset-management-inc-boosts-stake-in-cme-group-inc-nasdaqcme.html.
A number of brokerages recently weighed in on CME. Royal Bank Of Canada boosted their price objective on CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 20th. Deutsche Bank AG reduced their price objective on CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a research report on Tuesday, July 4th. Jefferies Group LLC restated a “buy” rating and set a $128.00 price objective on shares of CME Group in a research report on Monday, July 10th. BidaskClub upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Thursday, August 3rd. Finally, Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company’s stock. CME Group presently has an average rating of “Hold” and a consensus price target of $131.63.
In other news, Director Ronald A. Pankau sold 300 shares of CME Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $124.78, for a total transaction of $37,434.00. Following the completion of the transaction, the director now directly owns 4,009 shares in the company, valued at $500,243.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sunil Cutinho sold 10,265 shares of CME Group stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $117.85, for a total transaction of $1,209,730.25. Following the transaction, the insider now owns 21,690 shares of the company’s stock, valued at $2,556,166.50. The disclosure for this sale can be found here. Insiders sold 90,885 shares of company stock valued at $11,217,668 over the last 90 days. 0.61% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.